In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases

Muscular dystrophies, myopathies, and traumatic muscle injury and loss encompass a large group of conditions that currently have no cure. Myoblast transplantations have been investigated as potential cures for these conditions for decades. However, current techniques lack the ability to generate cel...

Full description

Bibliographic Details
Main Authors: Neeladri Chowdhury, Atsushi Asakura
Format: Article
Language:English
Published: Hindawi Limited 2017-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2017/3027520
id doaj-f857b19c6ceb45af9d46f573805ed5af
record_format Article
spelling doaj-f857b19c6ceb45af9d46f573805ed5af2020-11-24T21:18:35ZengHindawi LimitedStem Cells International1687-966X1687-96782017-01-01201710.1155/2017/30275203027520In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle DiseasesNeeladri Chowdhury0Atsushi Asakura1Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN 55455, USAStem Cell Institute, University of Minnesota Medical School, Minneapolis, MN 55455, USAMuscular dystrophies, myopathies, and traumatic muscle injury and loss encompass a large group of conditions that currently have no cure. Myoblast transplantations have been investigated as potential cures for these conditions for decades. However, current techniques lack the ability to generate cell numbers required to produce any therapeutic benefit. In utero stem cell transplantation into embryos has been studied for many years mainly in the context of hematopoietic cells and has shown to have experimental advantages and therapeutic applications. Moreover, patient-derived cells can be used for experimental transplantation into nonhuman animal embryos via in utero injection as the immune response is absent at such early stages of development. We therefore propose in utero transplantation as a potential method to generate patient-derived humanized skeletal muscle as well as muscle stem cells in animals for therapeutic purposes as well as patient-specific drug screening.http://dx.doi.org/10.1155/2017/3027520
collection DOAJ
language English
format Article
sources DOAJ
author Neeladri Chowdhury
Atsushi Asakura
spellingShingle Neeladri Chowdhury
Atsushi Asakura
In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
Stem Cells International
author_facet Neeladri Chowdhury
Atsushi Asakura
author_sort Neeladri Chowdhury
title In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
title_short In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
title_full In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
title_fullStr In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
title_full_unstemmed In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
title_sort in utero stem cell transplantation: potential therapeutic application for muscle diseases
publisher Hindawi Limited
series Stem Cells International
issn 1687-966X
1687-9678
publishDate 2017-01-01
description Muscular dystrophies, myopathies, and traumatic muscle injury and loss encompass a large group of conditions that currently have no cure. Myoblast transplantations have been investigated as potential cures for these conditions for decades. However, current techniques lack the ability to generate cell numbers required to produce any therapeutic benefit. In utero stem cell transplantation into embryos has been studied for many years mainly in the context of hematopoietic cells and has shown to have experimental advantages and therapeutic applications. Moreover, patient-derived cells can be used for experimental transplantation into nonhuman animal embryos via in utero injection as the immune response is absent at such early stages of development. We therefore propose in utero transplantation as a potential method to generate patient-derived humanized skeletal muscle as well as muscle stem cells in animals for therapeutic purposes as well as patient-specific drug screening.
url http://dx.doi.org/10.1155/2017/3027520
work_keys_str_mv AT neeladrichowdhury inuterostemcelltransplantationpotentialtherapeuticapplicationformusclediseases
AT atsushiasakura inuterostemcelltransplantationpotentialtherapeuticapplicationformusclediseases
_version_ 1726008433245683712